Source recordFED

Karaplis, Andrew C

Federal grants & contributions· Canadian Institutes of Health Research· FY2019· $895,050· QC

Description

CYP24A1 Enzymatic Activity in FGF23-Mediated Renal Phosphate Wasting Disorders

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$895,050$0Original · 2018-04-01 (start date) · total $895,050
  • #02018-04-01$895,050
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2018-04-01(start date)$895,050—CYP24A1 Enzymatic Activity in FGF23-Mediated Renal Phosphate Wasting Disorders

Related records · 2

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2023-2024-Q3-00230Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research$761,176FY2024
236-2020-2021-Q3-00368Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research$430,314FY2021

Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q4-00370 · retrieved 2026-11-15.